Development Program

Primary Biliary Cholangitis,
Primary Sclerosing Cholangitis
(PBC & PSC)

Aim

Identify novel compounds for treatment of patients with Primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC).

Brief description

Primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC) are chronic liver diseases that are in the worst case progressing towards liver failure with the need for liver transplantation. There is currently no cure for PBC or PSC and treatments consist of ursodeoxycholic acid and obeticholic acid. There is a clear medical need for novel therapeutic options to halt disease progression.

Status: Ongoing
Timeline: 2020 – now

Project Status

Partners

Get Involved

Learn how you can contribute to the exciting work happening at Delta4

Careers

Forging the innovative treatments of the future requires brilliant minds and we’re always on the lookout for talent.

Investors

Contact us to find out more about how you can invest with us and be a part of pioneering the next successful treatment.

Medical Community

Learn how you can partner with us and combine our technology with your knowledge to develop treatments faster.